Key Insights

Highlights

Success Rate

87% trial completion (above average)

Published Results

13 trials with published results (7%)

Research Maturity

78 completed trials (43% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.6%

12 terminated out of 181 trials

Success Rate

86.7%

+0.2% vs benchmark

Late-Stage Pipeline

13%

23 trials in Phase 3/4

Results Transparency

17%

13 of 78 completed with results

Key Signals

13 with results87% success12 terminated

Data Visualizations

Phase Distribution

111Total
Not Applicable (83)
P 1 (1)
P 2 (4)
P 3 (10)
P 4 (13)

Trial Status

Completed78
Unknown61
Recruiting20
Terminated12
Not Yet Recruiting4
Enrolling By Invitation3

Trial Success Rate

86.7%

Benchmark: 86.5%

Based on 78 completed trials

Clinical Trials (181)

Showing 20 of 20 trials
NCT07554352Not Yet RecruitingPrimary

Early Detection of COPD Exacerbations Using Home Monitoring Device

NCT04789057Phase 4Active Not Recruiting

Atorvastatin Effect on Reduction of COPD Exacerbations

NCT05825014RecruitingPrimary

Predicting Adverse Outcomes Using Machine Learning of COPD Patients in Hong Kong

NCT04223050Phase 4TerminatedPrimary

Comparing Mortality for Low vs High Peripheral Oxygen Saturation in COPD-patients With Acute Exacerbation

NCT05819164Not ApplicableCompletedPrimary

Comparison of Multiple Oxygenation Targets With Different Oximeters in Chronic Obstructive Pulmonary Disease (COPD) and Non-COPD Patients- Impact on Oxygen Flows

NCT07351929Not ApplicableRecruitingPrimary

Emotional-distress-based Integrated Care Programme in Patients With an Acute Exacerbation of COPD

NCT04320342Phase 3Completed

A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD

NCT07076290Phase 1Not Yet Recruiting

A Repeat Ascending Dosing Study of the Safety and Clinical Activity of R-3750 in Patients With Mild to Moderate COPD

NCT04481555Phase 4Completed

Eosinophil-guided Reduction of Inhaled Corticosteroids

NCT05443321Not ApplicableEnrolling By Invitation

Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes

NCT05492149Completed

Pulmonary Rehabilitation for COPD Patients: Can Performance Predict Exacerbation?

NCT06544928Enrolling By InvitationPrimary

Study on Home Obstructive Respiratory Exacerbations

NCT05897125Not ApplicableEnrolling By InvitationPrimary

Telehealth Education Leveraging Electronic Transitions Of Care for COPD Patients

NCT07302425Not ApplicableRecruitingPrimary

High-intensity Resistance Training in Post-exacerbation COPD

NCT04521608Not ApplicableCompletedPrimary

Increasing Adherence to Pulmonary Rehabilitation After COPD Related Hospitalizations (Study 2)

NCT07185581CompletedPrimary

Impulse Oscillometry in COPD Exacerbation

NCT01573481Not ApplicableCompleted

Comparison of Two Ventilator Mode During the Night: New Strategy of Mechanical Ventilation Weaning

NCT05829083Not ApplicableRecruitingPrimary

DUET Versus Standard Interface for Hypercapnic COPD Patients

NCT04136717Not ApplicableRecruitingPrimary

Influence of FreeO2 on Percentage of Time Within Oxygen Saturation Target Using Noninvasive Ventilation (NIV) and Continuous Positive Airway Pressure (CPAP) for Patients Admitted for AECOPD or Bariatric Surgery

NCT03835741Not ApplicableTerminated

Automated Adjustment of Oxygen on Patient With Acute COPD Exacerbation - FreeO2 HypHop

Scroll to load more

Research Network

Activity Timeline